Inhibrx Biosciences, Inc. INBX
- ordastobart — Non-Small Cell Lung Cancer Phase 1
- ordastobart — Head and Neck Squamous Cell Carcinoma Phase 2
OX40 (2 companies · 3 programs)
Companies with an active program directed at OX40.
Aptevo Therapeutics Inc. APVO
- APVO603 Preclinical